News

NASA has struggled to understand why many astronauts, upon returning from space missions, have experienced moderate to severe eye problems and changes to their vision, said Dorit Donoviel, PhD.

Valeant Pharmaceuticals International has acquired Nicox S.A.’s U.S. diagnostics subsidiary, Nicox, Inc., in a deal worth up to $20 million.

This collection of documents demonstrates the love and admiration that these distinguished individuals, all of whom are highly respected in the history of ophthalmology, have held for one another.

Seanna Grob MD, MAS, and Reza Dana, MD, MPH, MSc, present the second-place winning entry in Ophthalmology Times' Resident Writer's Award Program, sponsored by Allergan. In this case presentation, the treatment of dry eye disease in the setting of GVHD is a complicated condition that can have devastating effects if not diagnosed and treated in a timely fashion. Patients require close monitoring by an experienced cornea specialist and often need a combination of multiple available treatments to control symptoms and disease progression.

An examination on accountable care organizations and how they may impact ophthalmology.

To make the most of the limited time for seeing patients, it helps to structure visits for dry eye disease following a plan that addresses diagnosis, testing, education, and treatment, but also taps technology to improve efficiency and help patients find reliable information.

Should ophthalmologists be required to take courses on marijuana?

The Cliradex Complete Advanced Lid Hygiene Kit is a new product that may help manage symptoms of lid margin diseases. The kit’s Cliradex Advance Care gel-whose main component is 4-Terpineol-has a miticidal effect and cleansing properties that can help improve ocular health.

A new intraocular mini-telescope is easy to implant through a small incision and has optimized optics so that it reliably provides good quality vision.

Advances to an imaging technology may assist clinicians in improving a diagnosis of meibomian gland dysfunction with objective examination of patients’ tear film lipid layer, blink profile, and meibomian gland structure and function.

A therapeutic in development blocks interleukin-1-a major player in the initiation and maintenance of the inflammatory response-and may help patients with moderate to severe dry eye disease.

A line of products used for the temporary relief of burning and irritation caused by dry eye was shown to increased meibomian gland function from baseline compared with warm compresses.

A recent study demonstrates the importance of evaluating osmolarity during cataract surgical planning in order to ensure that presurgical keratometry readings are not compromised by hyperosmolarity of the ocular surface.

In the second of a two-part series, Arun C. Gulani, MD, reviews how to address lens-based surgeries when they are associated with previous radial keratotomy (RK). In the second of a two-part series, Arun C. Gulani, MD, reviews how to address lens-based surgeries when they are associated with previous radial keratotomy (RK).

Clinical study demonstrates impressive symptom relief for patients with evaporative dry eye disease

The first clear formulation of cyclosporine A 0.05% (CyclaSol, Novaliq) demonstrated excellent safety and tolerability in a phase I study.

A metabolomics study found a link between dry eye disease and androgen metabolism in females.

Medical information on the Internet is available 24/7 and knows no geographic limits. Patients can educate themselves while in bed, on the sofa, or while commuting. Such access facilitates saving time, money, and embarrassment for patients in the most rapid way possible. The plus side is that they can empower themselves with additional information, possibly motivating them to make a medical appointment and making them feel more prepared for that intervention, according to Ivan Goldberg, MBBS, FRANZCO.

A U.S. district court has ruled that Pershing Square Capital Management can vote its 9.7% stake in Allergan in a special shareholder meeting on Dec. 18.

Johnson & Johnson Vision Care (JJVC) announced the initial launch of 1-Day Acuvue Define brand contact lenses with Lacreon Technology, a new category of eye enhancement contact lenses that accentuate natural beauty while helping to support a healthy eye.

Richard Zorab, vice president for ophthalmic knowledge at the American Academy of Ophthalmology, has died at the age of 68.

The advent of anti-vascular endothelial growth factor (VEGF) therapy has been a tremendous advance for the treatment of retinal vein occlusion (RVO), but many other opportunities exist, said Joan W. Miller, MD.

The Center for Medicare and Medicaid Services (CMS) has granted billing and reimbursement statuses to products from Omeros Corp. and VisionCare Ophthalmic Technologies, respectively.

A retina specialist explains why vitrectomy surgery is safer and more efficient using a new ultra-high-speed vitrectomy cutting probe combined with 27+ gauge instrumentation.

A diet that contains lutein and zeaxanthin-or supplementation with these two carotenoids-appears to benefit healthy vision throughout life.

Knowing when to use laser therapy or injection therapy-either together or stand-alone-for diabetic macular edema is a crucial decision for the ophthalmologist.

Selective genotyping allows clinicians to implement individualized surveillance programs that may increase the detection of progression and decrease the burden of unnecessary frequent examinations.

Outcomes from a study of intravitreal aflibercept were evaluated for patients with and without prior anti-vascular endothelial growth factor therapy for diabetic macular edema.